MBX logo

MBX
MBX Biosciences Inc.

410
Mkt Cap
$1.5B
Volume
291,323.00
52W High
$45.85
52W Low
$9.43
PE Ratio
-14.23
MBX Fundamentals
Price
$31.76
Prev Close
$31.43
Open
$31.62
50D MA
$31.48
Beta
1.65
Avg. Volume
459,202.57
EPS (Annual)
-$2.38
P/B
3.42
Rev/Employee
$0.00
$778.30
Loading...
Loading...
News
all
press releases
This new GLP-1 play is on a tear. UBS sees nearly a 50% gain from here
MBX Biosciences has rallied more than 230% over the past year, but there's room for still more upside from current levels, according to UBS...
CNBC: Top News·9d ago
News Placeholder
More News
News Placeholder
MBX Biosciences (NASDAQ:MBX) Trading Down 6.3% - Should You Sell?
MBX Biosciences (NASDAQ:MBX) Trading Down 6.3% - Time to Sell...
MarketBeat·27d ago
News Placeholder
MBX Biosciences, Inc. (NASDAQ:MBX) Given Consensus Rating of "Moderate Buy" by Analysts
MBX Biosciences, Inc. (NASDAQ:MBX - Get Free Report) has received an average recommendation of "Moderate Buy" from the twelve brokerages that are presently covering the stock, MarketBeat Ratings...
MarketBeat·1mo ago
News Placeholder
MBX Biosciences, Inc. (NASDAQ:MBX) Short Interest Up 20.4% in March
MBX Biosciences, Inc. (NASDAQ:MBX - Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling...
MarketBeat·1mo ago
News Placeholder
MBX Biosciences (NASDAQ:MBX) Downgraded to "Sell" Rating by Wall Street Zen
Wall Street Zen lowered MBX Biosciences from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·1mo ago
News Placeholder
MBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading Volume - What's Next?
MBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading Volume - Time to Buy...
MarketBeat·1mo ago
News Placeholder
Lifesci Capital Weighs in on MBX Biosciences Q1 Earnings
MBX Biosciences, Inc. (NASDAQ:MBX - Free Report) - Analysts at Lifesci Capital issued their Q1 2026 earnings estimates for MBX Biosciences in a report released on Tuesday, March 31st. Lifesci Capital analyst P. Dolezal anticipates that the company will post earnings of ($0.66) per share for the quar...
MarketBeat·2mo ago
News Placeholder
MBX Biosciences (NASDAQ:MBX) Upgraded at Lifesci Capital
Lifesci Capital raised MBX Biosciences to a "strong-buy" rating in a report on Tuesday...
MarketBeat·2mo ago
News Placeholder
MBX Biosciences (NASDAQ:MBX) Shares Up 8.5% - What's Next?
MBX Biosciences (NASDAQ:MBX) Stock Price Up 8.5% - What's Next...
MarketBeat·2mo ago
News Placeholder
MBX Biosciences, Inc. (NASDAQ:MBX) Sees Large Increase in Short Interest
MBX Biosciences, Inc. (NASDAQ:MBX - Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 13th, there was short interest totaling 2,983,725 shares, a growth of 24.6% from the February 26th total of 2,395,339 shares. Based on an average...
MarketBeat·2mo ago
<
1
2
...
>

Latest MBX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.